In this episode, we discuss the role of broad-spectrum micronutrients (BSMs) in managing symptoms of ADHD. We examine the rationale behind opting for alternative therapies for this condition and dissect the outcomes of an RCT involving BSMs for ADHD. Could micronutrients provide a comprehensive strategy for treating ADHD, thereby enhancing overall mental wellness? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSM) for Mental Health: Context for Considering Micronutrient Treatment An Overview of Standard Treatment vs CAM for ADHD

Are you aware that a staggering 80% of ADHD patients report at least 1 side effect from their medication? In this episode, we discuss an analysis that seeks to answer an essential question: Can we predict medication nonadherence in adolescents and young adults with ADHD based on specific side effects? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 10 Reported Side Effects Associated With Medication Nonadherence Among Youth With ADHD

Did you know that your genes could affect how your brain processes vital nutrients? In this episode, we delve into fascinating research on micronutrient supplementation for mental disorders, such as ADHD. Discover how our genetic makeup might dictate our nutrient needs and how this can influence mental health outcomes. Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSM) for Mental Health: Context for Considering Micronutrient Treatment Rationale for Micronutrient Supplementation in Mental Illness  

This podcast explores the impact of antipsychotic switching on substance use in schizophrenia. It discusses the potential benefits of switching from risperidone to clozapine based on insights from national cohorts. The podcast also delves into a study comparing the effects of clozapine and risperidone on craving and brain activation in patients with dual diagnosis. It suggests that switching to clozapine may lead to better outcomes. The potential impact of switching antipsychotic medication on substance use in schizophrenia is further explored, with previous studies indicating a higher likelihood of alcohol remission with clozapine use. However, the side effects of clozapine should be considered.

Dive into the fascinating world of nutrition's impact on mental health in our latest episode. We explore intriguing studies on the Mediterranean diet's potential to alleviate depressive symptoms. Can a shift in dietary habits truly improve mental health? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSM) for Mental Health: Context for Considering Micronutrient Treatment Depression and Mediterranean-Style Diet

In this episode, we explore a pressing problem in pediatric psychiatry: The disparities in the use of pharmacologic restraints. How can we address these biases in our healthcare system? What role do behavioral interventions play in reducing the need for these measures? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 09 Disparities in Pharmacologic Restraint Use in Pediatric Emergency Departments

This episode explores clozapine-induced orthostasis and offers management strategies such as slow titration and fluid intake. The use of fludrocortisone for persistent orthostasis is also discussed.

In this episode, we discuss the potential of lavender extract, Silexan, as an alternative treatment for anxiety and insomnia with Dr. Jim Phelps. Is it truly a promising solution free from dependency and withdrawal symptoms or just an effective placebo? Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 48 Effect of Anxiolytic Drug Silexan on Sleep – A Narrative Review

Psychopharmacology expert, Jonathan Meyer, M.D., talks about the severe side effect of clozapine: constipation. He discusses the cause of constipation due to the drug's strong anticholinergic effects and effective management strategies such as using laxatives and tapering certain medications. The podcast also highlights the importance of managing treatment-resistant illness and provides insights on secretagogues for constipation in clozapine users.

A study on the cardiovascular risks of ADHD medication, highlighting elevated risks for those with preexisting cardiovascular diseases. Meta-analysis reveals recommendations for patient monitoring and caution. Discussion on the need for caution and further research in understanding the cardiovascular impact of ADHD medication.